News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
407,407 Results
Type
Article (26679)
Company Profile (71)
Press Release (380657)
Section
Business (114861)
Career Advice (472)
Deals (19324)
Drug Delivery (47)
Drug Development (50661)
Employer Resources (48)
FDA (12852)
Job Trends (8712)
News (203393)
Policy (21081)
Tag
Academia (1765)
Alliances (30666)
Alzheimer's disease (757)
Approvals (12841)
Artificial intelligence (104)
Bankruptcy (142)
Best Places to Work (7017)
Breast cancer (135)
Cancer (912)
Cardiovascular disease (78)
Career advice (430)
Cell therapy (151)
Clinical research (42229)
Collaboration (288)
Compensation (65)
COVID-19 (1527)
C-suite (67)
Data (987)
Diabetes (110)
Diagnostics (3599)
Earnings (39980)
Events (54137)
Executive appointments (257)
FDA (13390)
Funding (240)
Gene therapy (83)
GLP-1 (342)
Government (3071)
Healthcare (12484)
Infectious disease (1579)
Inflammatory bowel disease (73)
IPO (7790)
Job creations (1976)
Job search strategy (399)
Layoffs (158)
Legal (4217)
Lung cancer (149)
Lymphoma (64)
Manufacturing (83)
Medical device (12844)
Medtech (12848)
Mergers & acquisitions (11663)
Metabolic disorders (296)
Neuroscience (960)
NextGen Class of 2024 (4018)
Non-profit (2832)
Northern California (913)
Obesity (168)
Opinion (65)
Parkinson's disease (59)
Patents (64)
People (36304)
Phase I (12077)
Phase II (18274)
Phase III (15000)
Pipeline (306)
Postmarket research (1760)
Preclinical (3883)
Radiopharmaceuticals (160)
Rare diseases (125)
Real estate (3218)
Regulatory (14823)
Research institute (1630)
Southern California (796)
Startups (2312)
United States (8721)
Vaccines (307)
Weight loss (116)
Date
Last 7 days (358)
Last 30 days (1411)
Last 365 days (20953)
2024 (20859)
2023 (24076)
2022 (32786)
2021 (35129)
2020 (34395)
2019 (29955)
2018 (23055)
2017 (20513)
2016 (19615)
2015 (23131)
2014 (17580)
2013 (14711)
2012 (15833)
2011 (16251)
2010 (14817)
Location
Africa (396)
Arizona (93)
Asia (34252)
Australia (4991)
California (2014)
Canada (934)
China (238)
Colorado (108)
Connecticut (117)
Delaware (66)
Europe (53736)
Florida (333)
Georgia (84)
Illinois (264)
Indiana (158)
Japan (70)
Kansas (67)
Maryland (461)
Massachusetts (1462)
Michigan (77)
Minnesota (199)
New Jersey (742)
New York (618)
North Carolina (440)
Northern California (913)
Ohio (92)
Pennsylvania (578)
South America (572)
Southern California (796)
Texas (331)
Utah (65)
Washington State (160)
407,407 Results for "todos medical ltd".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
WORK Medical Technology Group LTD’s Subsidiary, Hangzhou Shanyou, Showcases Products at MEDICA Trade Fair 2024
November 28, 2024
·
4 min read
BioMidwest
Todos Medical Provides Corporate Update: Retooling to Focus on Long COVID Epidemic
Todos Medical, Ltd., an innovative healthcare solutions company, provided a corporate update to its stakeholders centered on the Company’s efforts to retool and focus primarily on addressing the Long COVID epidemic that is affecting over 15 million Americans, over 6% of the adult US population, according to the US Centers for Disease Control.
September 26, 2023
·
7 min read
Meihua International Medical Technologies Co., Ltd. Announces Share Repurchase Program of Up to $3 million
Meihua International Medical Technologies Co., Ltd., a reputable manufacturer and provider of Class I, II and III disposable medical devices with operating subsidiaries in China, announced that its board of directors has approved and authorized a share repurchase program of up to $3 million of the Company’s outstanding ordinary shares.
July 1, 2024
·
5 min read
Press Releases
Medicus Pharma Ltd. Appoints Faisal Mehmud, MD, MRCP as Chief Medical Officer
November 18, 2024
·
7 min read
Press Releases
Inari Medical Announces Reimbursement Approval for ClotTriever® Thrombectomy System in Japan and New Distribution Partnership with Medikit Co., Ltd.
December 3, 2024
·
4 min read
Press Releases
Lakeside Holding Enters Medical Logistics Sector with Acquisition of Hupan Pharmaceutical (Hubei) Co., Ltd.
November 11, 2024
·
4 min read
Pharm Country
Todos Medical Provides Corporate Update - February 23, 2023
Todos Medical, Ltd., a comprehensive medical diagnostics and related solutions company, provided a corporate update for shareholders.
February 23, 2023
·
11 min read
Business
Meihua International Medical Technologies Co., Ltd. Reports 2023 Financial Year Results
Meihua International Medical Technologies Co., Ltd., a reputable manufacturer and provider of Class I, II, and III disposable medical devices with operating subsidiaries in China, reported its financial results for the fiscal year ended December 31, 2023.
April 24, 2024
·
14 min read
BioMidwest
Todos Medical Enters Into Moratorium on Conversions Agreement With Convertible Note Holders
Todos Medical, Ltd., a comprehensive medical diagnostics and related solutions company, announced the Company has entered into a new agreement with holders of its convertible notes that provides for a 21-day moratorium on conversion of those convertible notes.
March 13, 2023
·
5 min read
Deals
Todos Medical Begins Trading on the OTC Pink Marketplace
Todos Medical, Ltd. today announced that its Ordinary shares will begin trading on the OTC Pink marketplace beginning on March 27, 2023 as a result of the Company’s closing bid price falling below $0.001 for 5 consecutive trading days, from March 20, 2023 through March 24, 2023.
March 27, 2023
·
4 min read
1 of 40,741
Next